Idiopathic Pulmonary Fibrosis Latest Advances

Find the Latest Research About Idiopathic Pulmonary Fibrosis

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11609 publications

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Journal: Pulmonology
Published: June 24, 2026

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Journal: Respiratory medicine
Published: June 21, 2026

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Journal: Current opinion in pulmonary medicine
Published: June 18, 2026

Effect of Dietary Nitrate Supplementation on Exercise Performance in Hypoxic IPF (EDEN-OX3): a double-blind, placebo-controlled, randomised crossover study.

Effect of Dietary Nitrate Supplementation on Exercise Performance in Hypoxic IPF (EDEN-OX3): a double-blind, placebo-controlled, randomised crossover study.

Journal: Thorax
Published: June 17, 2026

Potential Roles of Gut Microbiome and Metabolomes in Interstitial Lung Disease: Evidence across Preclinical and Clinical Research.

Potential Roles of Gut Microbiome and Metabolomes in Interstitial Lung Disease: Evidence across Preclinical and Clinical Research.

Journal: Journal of applied microbiology
Published: June 15, 2026

Pulmonary fibrosis: Emerging targets and novel therapeutics.

Pulmonary fibrosis: Emerging targets and novel therapeutics.

Journal: The Journal of international medical research
Published: June 15, 2026

Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular Programs.

Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular Programs.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Integrated Multi-Omics Profiling Reveals Coordinated Transcriptional, Translational, and Metabolic Remodeling in IPF Fibroblasts.

Integrated Multi-Omics Profiling Reveals Coordinated Transcriptional, Translational, and Metabolic Remodeling in IPF Fibroblasts.

Journal: DNA and cell biology
Published: June 12, 2026

Sustained Yap/Taz activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling.

Sustained Yap/Taz activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling.

Journal: JCI insight
Published: June 09, 2026

Reframing Ultrasound-Based Dyspnea Models for Idiopathic Pulmonary Fibrosis.

Reframing Ultrasound-Based Dyspnea Models for Idiopathic Pulmonary Fibrosis.

Journal: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Published: June 09, 2026

Kuwanon C alleviates pulmonary fibrosis via activation of the Nrf2 signaling pathway.

Kuwanon C alleviates pulmonary fibrosis via activation of the Nrf2 signaling pathway.

Journal: Journal of Asian natural products research
Published: June 08, 2026
Showing 1-12 of 11,609

Last Updated: 06/30/2026